NexaVita XB provides hands-on product strategy and commercial leadership to help European Life Sciences, MedTech, FemTech, and B2B manufacturing scale-ups accelerate growth and expand into the U.S. With deep expertise and a flexible engagement model, we become a true extension of your team bringing the leadership and commercial firepower you need, exactly when you need it. We support growth-stage companies through the critical phases that define U.S. market success: product-market fit validation, go-to-market execution, market entry, and investor engagement. Our work spans product positioning, pricing strategy, competitive roadmaps, and launch planning. We work with you so your innovation reaches the right customers with real commercial impact. Whether you are entering the U.S. for the first time or scaling an existing footprint, we offer tailored support through fractional executive roles, interim leadership, and project-based consulting. We help you build a credible U.S. presence through local commercial leadership, strategic partnerships, sales enablement, and KOL development. Alongside our direct engagement, we bring a strong network of industry experts, investors, and advisors so you can move faster and more confidently toward your goals. From aligning your team around a strategy to executing in complex, regulated markets, NexaVita XB is the partner you want in your corner as you scale across borders.
The costs depend on the type of engagement and set up, starting at €5000.
Are you in doubt if this is the right service for you, or do you want to get more information about the service? Get in touch with the EIC Partner providing this service through this query form!
Is this the service you are looking for? If so, you can apply to the service through EIC ACCESS+! Eligible applicants can also get co-funding through the EIC ACCESS+ initiative. Find out more on the project website.
Receive up to €60,000 in grants, covering up to 50% of the costs, to access specialised services from the EIC Service Catalogue. Learn more on the EIC ACCESS+ website.